Cargando…

Vancomycin MIC Distribution among Methicillin-Resistant Staphylococcus Aureus. Is Reduced Vancomycin Susceptibility Related To MIC Creep?

AIM: To determine the distribution of vancomycin MIC and the frequency of S. aureus strains with reduced vancomycin susceptibility among Methicillin-Resistant Staphylococcus aureus (MRSA) isolates. METHODS: MRSA isolates (n = 100) were tested for reduced susceptibility to vancomycin using MIC broth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Othman, Hala B., Halim, Rania M. Abdel, Gomaa, Fatma Alzahraa M., Amer, Malaka Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Republic of Macedonia 2018
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352480/ https://www.ncbi.nlm.nih.gov/pubmed/30740152 http://dx.doi.org/10.3889/oamjms.2019.009

Ejemplares similares

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality
por: Hsieh, Yu-Chia, et al.
Publicado: (2016)

Is vancomycin MIC creep a worldwide phenomenon? Assessment of S. aureus vancomycin MIC in a tertiary university hospital
por: Joana, Silvestre, et al.
Publicado: (2013)

Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (‘the MIC Creep’): implications for therapy
por: Dhand, Abhay, et al.
Publicado: (2012)

Assessment of Vancomycin MIC Creep Phenomenon in Methicillin-Resistant Staphylococcus aureus isolates in a Tertiary Care Hospital of Lahore
por: Arshad, Faiqa, et al.
Publicado: (2020)

Different Antimicrobial Susceptibility Testing Methods to Determine Vancomycin Susceptibility and MIC for Staphylococcus aureus with Reduced Vancomycin Susceptibility
por: Chung, Hae-Sun, et al.
Publicado: (2022)

The Association of Molecular Characteristics, Vancomycin MIC and Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Osteoarticular Infections in Children
por: McNeil, Jonathon, et al.
Publicado: (2017)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
por: San-Juan, Rafael, et al.
Publicado: (2016)

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010)

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus
por: Eum, Seenae, et al.
Publicado: (2016)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

Staphylococcus aureus bacteremia in a secondary level Spanish hospital: clinical implications of high vancomycin MIC
por: Abelenda Alonso, Gabriela, et al.
Publicado: (2018)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

397 Correlation between calculated vancomycin AUC(0-24)/MIC and acute kidney injury in patients with Methicillin Resistant Staphylococcus Aureus bacteraemia
por: Ghosh, Niladri, et al.
Publicado: (2014)

473 Comparison of MicroScan System Prompt and Turbidity Methods for Measuring Vancomycin Minimum inhibitory concentration (MIC) against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 2ug/ml, the Clinical Implications and economic impact of using alternative antimicrobial agents to vancomycin for MRSA with possible MIC of 2ug/ml
por: Kamran, Amir, et al.
Publicado: (2014)

Molecular characterisation and epidemiology of transmission of intraoperative Staphylococcus aureus isolates stratified by vancomycin minimum inhibitory concentration (MIC)
por: Hadder, Brent, et al.
Publicado: (2022)

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method
por: Wang, Jiun-Ling, et al.
Publicado: (2010)

Decreased Vancomycin MICs among Methicillin-Resistant Staphylococcus aureus Clinical Isolates at a Chinese Tertiary Hospital over a 12-year Period
por: Lu, Chaohui, et al.
Publicado: (2016)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

EVALUATION OF METHODS IN DETECTING VANCOMYCIN MIC AMONG MRSA ISOLATES AND THE CHANGES IN ACCURACY RELATED TO DIFFERENT MIC VALUES
por: Rossatto, Fernanda Cristina Possamai, et al.
Publicado: (2014)

Rising incidence of high MIC for vancomycin among Staphylococcus aureus strains at a tertiary care hospital in South India
por: Ramana, Banda Venkata, et al.
Publicado: (2012)

Proportion of Staphylococcus aureus with a Vancomycin Minimum Inhibitory Concentration (MIC) of 1 mg/L Increases Between 2012 and 2017 in Singapore
por: Mendis, Shehara M, et al.
Publicado: (2017)

Reduced Susceptibility to Vancomycin in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2011)

Evaluating vancomycin susceptibility in Staphylococcus aureus
por: Mimica, Marcelo J, et al.
Publicado: (2016)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

Differences in Method-Specific Vancomycin MICs and Induced Daptomycin Resistance in an Infective Endocarditis Patient
por: Lash, David Benjamin, et al.
Publicado: (2015)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

MIC and MBC of Honey and Gold Nanoparticles against methicillin-resistant (MRSA) and vancomycin-resistant (VRSA) coagulase-positive S. aureus isolated from contagious bovine clinical mastitis
por: Omara, Shimaa T.
Publicado: (2017)

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
por: Hu, Jian, et al.
Publicado: (2013)

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
por: Honda, Hitoshi, et al.
Publicado: (2011)

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
por: Peng, Huagang, et al.
Publicado: (2018)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
por: Katayama, Yuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o0h8dl1lej10o0auf5uojvedb1